Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
Pharmasyntez-Medtech
BratskChemSyntez
Export
Аll
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
04.04.2025
Vikram Punia, Founder and President of the Pharmasyntez Group in Forbes' 2025 World Billionaires Ranking
Read more
23.03.2025
Pharmasyntez Group to Begin Exporting Medicines to North Africa
Read more
19.03.2025
Pharmasyntez becomes Title Partner of the 24th Pharmacy Summit
Read more
15.03.2025
The Pharmasyntez Group participated in BIOCHINA 2025 in Suzhou
Read more
09.03.2025
Warmest birthday wishes to Nikita Vikramovich Punia, Executive Director of the Pharmasyntez Group!
Read more
06.03.2025
The Pharmasyntez Group took part in the II Forum “Women for a Healthy Society” held at the initiative of the Federation Council of the Federal Assembly of the Russian Federation
Read more
21.02.2025
According to the DSM Group agency's National Pharmaceutical Rating, the Pharmasyntez Group of Companies was recognized as Manufacturer No. 1 in 2024 for public procurement of packaged goods
Read more
16.02.2025
Congratulations to Pharmasyntez-Tyumen on its 10th anniversary - 10 years of successful work!
Read more
14.02.2025
A plant for the production of dialysis supplies and equipment will be built by the Pharmasyntez Group of Companies
Read more
04.02.2025
Pharmasyntez JSC presents a new anti-hepatitis C medication
Read more
30.01.2025
Technopolis Moscow Special Economic Zone (SEZ) resident status was granted to the Pharmasyntez Group
Read more
28.12.2024
Pharmasyntez-Nord JSC obtained ANSIVA’s GMP certificate in Brasilia
Read more
21.12.2024
Dutasteride + Tamsulosin, a new combination pharmaceutical product was introduced into civil circulation by Pharmasyntez JSC
Read more
09.12.2024
Pharmasyntez Group delivers humanitarian aid to cyclone-hit Republic of the Union of Myanmar
Read more
19.11.2024
Pharmasyntez launches new anesthetic drug Longradax for commercial use
Read more
18.10.2024
Pharmasyntez gathers leading experts to discuss measures for developing comprehensive import substitution in dialysis
Read more
News:
← предыдущая
1
2
3
4
5
следующая →
About
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
Pharmasyntez-Medtech
BratskChemSyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez
Pharmasyntez-Medtech